BioSpace News Archive

Ginkgo Bioworks Holdings, Inc. announced today that management is scheduled to participate in a panel discussion titled " Generative AI & Innovation Across Drug Discovery, Molecule Synthesis, & Precision Medicine " at the UBS MedTech, Tools and Genomics Summit 2023 on Tuesday, August 15 at 2:00 p.m. Pacific Time.

Rocket Pharmaceuticals, Inc. today reported financial results for the quarter ending June 30, 2023, and updates from the Company’s key pipeline developments, business operations and upcoming milestones.

Bristol Myers Squibb (NYSE: BMY) today announced that it has entered into accelerated share repurchase (ASR) transactions under agreements with each of Bank of America, N.A., Citibank, N.A., JPMorgan Chase Bank, N.A. and Morgan Stanley & Co. LLC (collectively, the “ASR Agreements”), to repurchase, in aggregate, $4 billion of Bristol Myers Squibb common stock.

Werewolf Therapeutics, Inc. today provided a business update and reported financial results for the second quarter ended June 30, 2023.

Reneo Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2023 and provided a business update.

Aprea Therapeutics, Inc. today reported financial results for the three and six months ended June 30, 2023 and provided a business update.

Alimera Sciences, Inc. today announced financial results for the second quarter of 2023.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today provided an update on its ongoing Phase 2 LUNA trial evaluating ixoberogene soroparvovec (Ixo-vec) for the treatment of wet age-related macular degeneration (wet AMD) and reported financial results for the second quarter ended June 30, 2023.

Alpha Teknova, Inc., a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, announced financial results for the second quarter ended June 30, 2023.

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the H.C. Wainwright Immune Cell Engager Virtual Conference on Thursday, August 17 at 9:00 a.m. ET.